Insmed Incorporated logo

Insmed Incorporated

NASDAQ:INSM

Overview | Financials
Company Name Insmed Incorporated
Symbol INSM
Currency USD
Price 68.32
Market Cap 11,740,723,680
Dividend Yield 0%
52-week-range 21.92 - 80.53
Industry Biotechnology
Sector Healthcare
CEO Mr. William H. Lewis J.D., M.B.A.
Website https://www.insmed.com

An error occurred while fetching data.

About Insmed Incorporated

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of

Related Stocks

OPKO Health, Inc. logo

OPKO Health, Inc.

OPK

1.51 USD

Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

IOVA

11.19 USD

EQRx, Inc. logo

EQRx, Inc.

EQRX

2.34 USD

Axonics, Inc. logo

Axonics, Inc.

AXNX

70.37 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

22.93 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

40.47 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.64 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

26.9 USD

AdaptHealth Corp. logo

AdaptHealth Corp.

AHCO

10.5 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

47.62 USD

Financials

Numbers are in millions USD

Numbers are in millions USD